26 April 2024
1300 794 893

Switzer TV

Switzer Investing TV | 22nd April 2024

Don’t fear this market sell-off — it’s a buying opportunity! + Jun Bei Liu gives us stocks she’s buying now.

More videos

Mad about Money Live

Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.

Series: ,
Tech stocks on the slide! Which stocks are the best buys?

On this week's show, Peter Switzer is joined by Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, Tribeca Investment Partners' Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
How to boost your immunity

Dr Ross Walker explains how you can boost your immunity and which vitamins will give you an extra boost.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
7 Experts! Their One Best Stock! Plus, CEO of NextDC - Check Out The Future!

Peter Switzer talks to the experts about the best companies coming out of reporting season, plus NextDC CEO Craig Scroggie.

Series: ,
COVID-19 and your immunity

Dr Ross Walker looks at how your immunity affects your risk of contracting Coronavirus.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for another live episode of Mad about Money.

Series: ,
CEOs of BHP, Coles, Tyro, Domino's, Coca Cola & A2 Milk. Buy or Sell?

Peter Switzer talks to CEOs and a CFO from some of the biggest companies reporting in the past week, plus a catch up with Julia Lee.

Series: ,
COVID-19 vaccine update

Dr Ross Walker explains two promising COVID-19 vaccine trials and what they have been able to achieve.

Series: ,
Mad about Money

Tune in to find out the latest money news locally and overseas with Peter Switzer and Paul Rickard.

Series: ,
The hot companies to follow out of reporting season!

Peter Switzer speaks to Burman Invest's Julia Lee and Shaw and Partners' Adam Dawes about what companies to watch, plus Ruslan Kogan joins the show.

Series: ,
A treatment for mild to moderate COVID-19

Dr Ross Walker shares the details of a treatment plan with positive results in some mild to moderate cases of Coronavirus.

Series: ,
1 36 37 38 39 40 46
Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
1300 794 893
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram